Company / Cash & Equivalents
HCA Healthcare Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$1.0B
FY2025
5-year range
$908.0M / $1.9B
FY2021-FY2025
Trend
-46.2%
vs FY2024
Sector context
#28 of 148
Health Care
What the data says
HCA Healthcare's cash & equivalents of $1.0B is higher than 81% of companies in the Health Care sector (FY2025). Cash & Equivalents has fluctuated over the past 10 years, ranging from $502M in FY2018 to $1.9B in FY2024.
Based on SEC 10-K filings.
$1.0B in FY2025 with a 5-year CAGR of -10.3%. Top quartile in the Health Care sector.
Improved from $935M to $1.0B over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +4.6%
- 5-Year CAGR
- -10.3%
- 10-Year CAGR
- -
Sector benchmark
-11.6% below sector average
Key checks
Key Insights
- 5-year CAGR of -10.3%, indicating a declining trend.
- In FY2025, cash & equivalents decreased 46.2% year-over-year.
- Ranks #28 out of 148 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.0B | -46.2% |
| FY2024 | $1.9B | +106.7% |
| FY2023 | $935.0M | +3.0% |
| FY2022 | $908.0M | -37.4% |
| FY2021 | $1.5B | -19.1% |
| FY2020 | $1.8B | +188.7% |
| FY2019 | $621.0M | +23.7% |
| FY2018 | $502.0M | -31.4% |
| FY2017 | $732.0M | +13.3% |
| FY2016 | $646.0M | -12.8% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026